http://www.finance.senate.gov/ranking-members-news/wyden-grassley-sovaldi-investigation-finds-revenue-driven-pricing-strategy-behind-84-000-hepatitis-drug

http://economictimes.indiatimes.com/pharma/expensive-hepatitis-c-drug-pushes-people-to-make-their-own-medicines/articleshow/53071088.cms - evidence of people in LDCs turning to extreme means to get the drug.

